Hillenbrand's fiscal third quarter 2025 saw a significant 24% decrease in revenue to $599 million and a 40% drop in adjusted EPS to $0.51, largely impacted by the divestiture of the MIME business and reduced capital equipment volume. Despite these challenges, the company made progress on strategic initiatives, including debt reduction through asset sales and achieving cost synergies from recent acquisitions, demonstrating resilience amidst macroeconomic uncertainties.
Revenue for the fiscal third quarter 2025 was $599 million, a 24% decrease compared to the prior year, primarily due to the MIME business divestiture and lower capital equipment volume in APS.
GAAP EPS increased to $0.03 from $(3.53) in the prior year, while adjusted EPS decreased by 40% to $0.51, mainly attributed to the MIME divestiture and lower volume.
The company successfully achieved $30 million in run-rate cost synergies from the Linxis and FPM acquisitions earlier than planned, enhancing the Food, Health, and Nutrition business.
Hillenbrand reduced debt by over $300 million during the fiscal year through proceeds from the MIME divestiture and the sale of its minority interest in TerraSource, improving its net debt to pro forma adjusted EBITDA ratio to 3.9x.
Hillenbrand is updating its core outlook for fiscal year 2025, maintaining the midpoint of its full-year adjusted EPS range based on year-to-date performance and its outlook for the fiscal fourth quarter.
Visualization of income flow from segment revenue to net income